Fhit and p53 in Lung Cancer
Author Information
Author(s): Chang Y-L, Wu C-T, Shih J-Y, Lee Y-C
Primary Institution: National Taiwan University Hospital
Hypothesis
The study investigates the role of Fhit and p53 gene alterations in non-small-cell lung cancers (NSCLCs) and their correlation with clinical features.
Conclusion
The study found that Fhit expression is significantly reduced in squamous cell carcinomas and associated with smoking history, while p53 overexpression is linked to poorer survival in adenocarcinoma patients.
Supporting Evidence
- Fhit protein expression was detected in 41% of lung cancers, with significant differences based on smoking history.
- p53 overexpression was observed in 34% of cases and was significantly associated with poorer survival in adenocarcinoma.
- Loss of Fhit expression was more frequent in squamous cell carcinomas compared to adenocarcinomas.
Takeaway
This study looked at two important genes in lung cancer and found that one gene is often missing in smokers, while another gene's overactivity can lead to worse outcomes for patients.
Methodology
The study used immunohistochemistry to analyze Fhit and p53 protein expression in lung cancer specimens from patients who underwent surgical resection.
Potential Biases
The study may have bias due to the predominance of male patients and the limited number of female smokers.
Limitations
The study did not include patients treated with neoadjuvant chemotherapy or irradiation therapy, and some clinical data were missing for a few patients.
Participant Demographics
The study included 143 male and 120 female patients with a mean age of 64 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website